Assoc Prof Dr. Cheng-tien Wu | Authentic Leadership | Best Researcher Award | 2860

Assoc Prof Dr. Cheng-tien Wu | Authentic Leadership | Best Researcher Award

Assoc Prof Dr. Cheng-tien Wu, Taiwan

🔗 Professional Profiles

Summary:

Associate Professor specializing in Toxicology and Biochemistry/Medical at China Medical University, Taiwan. Experienced in nutrition research, with a focus on kidney health, inflammation, and fibrosis.

Education:

  • Ph.D. in Toxicology, National Taiwan University, Taiwan, 2010
  • M.Sc. in Biochemistry/Medical, Chung Shan Medical University, Taiwan, 2004
  • B.Sc. in Food Science/Nutrition, Fu Jen Catholic University, Taiwan, 1999

Professional Experience:

  • Associate Professor, Department of Nutrition, China Medical University, Taiwan (2013 – Present)
  • Assistant Professor, Department of Nutrition, China Medical University, Taiwan (2019 – 2023)
  • Medical Investigator, Taipei Medical University – Shuang Ho Hospital, Taiwan (2018 – 2019)
  • Senior Editor, Medjaden Bioscience Ltd., Hong Kong (2017 – Present)
  • Study Director, Level Biotechnology Inc., Taiwan (2015 – 2017)

Research Interest:

  • Kidney Health 🥦
  • Inflammation and Fibrosis 🧬
  • Functional Foods and Nutritional Interventions 🍎

Selected Publications:

  • Withaferin A Protects Against ER Stress-Associated Apoptosis, Inflammation, and Fibrosis in Kidneys (Phytomedicine, 2020)
  • Antifibrotic Effects of Icariin on Kidneys (Phytomedicine, 2019)
  • Genotoxicity and Oral Toxicity Studies of Functional Food Mixtures (RegulToxicolPharmacol, 2018)
  • Plasticizer Induced Renal Fibrosis (ToxicolSci, 2018)
  • Effects of Arsenic on Bone Health (Environ Health Perspect, 2014)

Publication Top Noted

Wogonin ameliorates ER stress-associated inflammatory response, apoptotic death and renal fibrosis in a unilateral ureteral obstruction mouse model

    • Authors: Kuo, H.-L., Chuang, H.-L., Chen, C.-M., Yang, S.-F., Wu, C.-T.
    • Journal: European Journal of Pharmacology
    • Volume: 977
    • Issue: Not specified
    • Pages: 176676
    • Year: 2024

Involvement of AMPKα and MAPK-ERK/-JNK Signals in Docetaxel-Induced Human Tongue Squamous Cell Carcinoma Cell Apoptosis

    • Authors: Su, C.-C., Lin, J.-W., Chang, K.-Y., Fang, K.-M., Chen, Y.-W.
    • Journal: International Journal of Molecular Sciences
    • Volume: 23
    • Issue: 22
    • Pages: 13857
    • Year: 2022

Therapeutic Effect of Icaritin on Cerebral Ischemia-Reperfusion-Induced Senescence and Apoptosis in an Acute Ischemic Stroke Mouse Model

    • Authors: Wu, C.-T., Yang, T.-H., Chen, M.-C., Chen, C.-M., Liu, S.-H.
    • Journal: Molecules
    • Volume: 27
    • Issue: 18
    • Pages: 5783
    • Year: 2022

Therapeutic effect of quercetin polymeric nanoparticles on ischemia/reperfusion-induced acute kidney injury in mice

    • Authors: Huang, K.-T., Wu, C.-T., Chang, Y., Chiang, C.-K., Liu, S.-H.
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 608
    • Issue: Not specified
    • Pages: 122–127
    • Year: 2022

Nobiletin Alleviates Ferroptosis-Associated Renal Injury, Inflammation, and Fibrosis in a Unilateral Ureteral Obstruction Mouse Model

    • Authors: Lo, Y.-H., Yang, S.-F., Cheng, C.-C., Guan, S.-S., Wu, C.-T.
    • Journal: Biomedicines
    • Volume: 10
    • Issue: 3
    • Pages: 595
    • Year: 2022

Maxim Svetlov-Transformational Leadership-Best Researcher  Award 

Maxim Svetlov-Transformational Leadership-Best Researcher  Award 

University of Illinois at Chicago-United States 

Author Profile 

Early Academic Pursuits

Maxim (Maksim) Svetlov began his academic journey with a Bachelor's degree in Biochemistry from Udmurt State University, Russia, in the year 2000. Building upon this foundation, he pursued a Master's degree in Biochemistry at the same institution, completing it in 2002. His academic pursuits took a significant leap as he delved into Molecular Biology for his Ph.D. at the Institute of Protein Research, RAS, Russia, achieving this milestone in January 2010.

Professional Endeavors

Following the completion of his Ph.D., Maxim Svetlov embarked on a dynamic career path. He served as a Senior Research Scientist at the Institute of Protein Research, Russian Academy of Sciences, Pushchino, Russia, from 2010 to 2015, contributing significantly to the field under the guidance of Dr. Alexander Spirin. Later, he transitioned to a Postdoctoral fellowship at the University of Illinois at Chicago, spending the years 2015 to 2019 in the laboratory of Dr. Alexander Mankin. Currently, he holds the position of Research Assistant Professor at the University of Illinois at Chicago since 2019.

Contributions and Research Focus

Maxim Svetlov's contributions to the field of molecular biology and antibiotic research are marked by several groundbreaking studies. Notably, his work on the mechanisms of antibiotic-induced cidality, inhibitory action of macrolide-ketolide antibiotics, and the interaction of ribosome-targeting drugs with bacterial and eukaryotic ribosomes has significantly advanced our understanding of these critical areas. His investigations into the molecular mechanism of resistance to ribosome-targeting antibiotics and the cotranslational folding of nascent peptides on the bacterial ribosome have further enriched the scientific community's knowledge.

Accolades and Recognition

Maxim Svetlov's dedication and excellence in research have not gone unnoticed. In 2010, he received the Best Scientific Project award from the Institute of Protein Research, followed by another accolade in 2011 for the same recognition. His exceptional work in the field has earned him the Best Researcher Award in Decision-making and Problem-solving.

Impact and Influence

Maxim Svetlov's research has had a profound impact on the field, as evidenced by the publication of numerous papers in prestigious scientific journals. His work has provided crucial insights into antibiotic mechanisms, resistance, and ribosome-associated quality control mechanisms in bacteria. These findings contribute significantly to the development of novel therapeutic strategies and our understanding of fundamental biological processes.

Legacy and Future Contributions

As a researcher, Maxim Svetlov's legacy lies in his commitment to unraveling the complexities of molecular biology and antibiotic action. His work sets the stage for future advancements in the field, inspiring new generations of scientists to explore the intricate mechanisms governing cellular processes. With a focus on ribosome-associated quality control and antibiotic resistance, his ongoing and future contributions are anticipated to further shape the landscape of molecular biology research.

This narrative showcases Maxim Svetlov's academic journey, professional achievements, and the profound impact of his research on the scientific community.

Notable Publications